Fifteen Years of Population-Based Breast Cancer Screening in the Netherlands

Seminars in Breast Disease

Volumn 10, Issue 2, 2007, Pages 72-82

  Fracheboud, Jacques ^a   Groenewoud, Johanna H ^a   de Koning, Harry J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

breast cancer; mammography; population based; screening

Indexed keywords

ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL ASSESSMENT; EARLY DIAGNOSIS; HEALTH PROGRAM; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; NETHERLANDS; PARTIAL MASTECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; SCREENING TEST; XEROMAMMOGRAPHY;

EID: 36448943894     PISSN: 10924450     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sembd.2007.09.004     Document Type: Article

References (58)

1. Wilson J.M.G., and Jungner G. Principles and Practice of Mass Screening for Disease (1968), World Health Organization, Geneva
2. Cancer incidence in five continents Volume VIII (2002) Report No.: 0300-5038
3. Sant M., Capocaccia R., Coleman M.P., et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 37 (2001) 1659-1667
4. IARC Handbooks of Cancer Prevention. Breast Cancer Screening (2002), IARC Press, Lyon
5. Kriege M., Brekelmans C.T., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 (2004) 427-437
6. Nyström L., Rutqvist L.E., Wall S., et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341 (1993) 973-978
7. Nyström L., Andersson I., Bjurstam N., et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359 (2002) 909-919
8. de Koning H.J., Boer R., Warmerdam P.G., et al. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 87 (1995) 1217-1223
9. de Waard F., Collette H.J.A., and Rombach J.J. Het DOM-project voor de vroege opsporing van borstkanker te Utrecht. Utrecht, Preventicon (1986) Report No.: deel 3
10. Collette H.J., Day N.E., Rombach J.J., et al. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet 1 (1984) 1224-1226
11. Verbeek A.L., Hendriks J.H., Holland R., et al. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet 1 (1984) 1222-1224
12. Collette H.J.A., Collette C., Rombach J.J., et al. Het DOM-project voor de vroege opsporing van borstkanker te Utrecht. Vakgroep Algemene Gezondheidszorg en Epidemiologie (1992), Rijksuniversiteit Utrecht, Utrecht Report No.: deel 4
13. de Koning H.J., van Ineveld B.M., van Oortmarssen G.J., et al. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49 (1991) 531-537
14. van Oortmarssen G.J., Habbema J.D., van der Maas P.J., et al. A model for breast cancer screening. Cancer 66 (1990) 1601-1612
15. de Haes J.C., de Koning H.J., van Oortmarssen G.J., et al. The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer 49 (1991) 538-544
16. Shapiro S., Coleman E.A., Broeders M., et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol 27 (1998) 735-742
17. Ballard-Barbash R., Klabunde C., Paci E., et al. Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment. Eur J Cancer Prev 8 (1999) 417-426
18. In: Perry N., Broeders M., de Wolf C., et al. (Eds). European Guidelines for Quality Assurance in Mammography Screening. (ed 4). (2006), European Communities, Luxembourg
19. Aro A.R., Absetz-Ylostalo P., Eerola T., et al. Pain and discomfort during mammography. Eur J Cancer 32A (1996) 1674-1679
20. American College of Radiology. Breast iMaging Reporting and Data System (BI-RADSTM) (1995), ACR, Reston, VA
21. Groenewoud J.H., Otten J.D.M., Fracheboud J., et al. Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands. Breast Cancer Res Treat 102 2 (2007) 211-218
22. NETB (National Evaluation Team for Breast cancer screening in the Netherlands). National Evaluation of Breast Cancer Screening in the Netherlands. Ninth evaluation report (in Dutch, with English summary) (2001), Erasmus MC Rotterdam, Rotterdam, Dept. of Public Health
23. NETB (National Evaluation Team for Breast cancer screening in the Netherlands). National Evaluation of Breast Cancer Screening in the Netherlands. Eleventh evaluation report (in Dutch, with English summary) (2005), Erasmus MC Rotterdam, Rotterdam, Dept. of Public Health
24. Bulliard J.L., Sasieni P., Klabunde C., et al. Methodological issues in international comparison of interval breast cancers. Int J Cancer 119 (2006) 1158-1163
25. CBO, Kwaliteitsinstituut voor de Gezondheidszorg. Mammacarcinoom: Screening en Diagnostiek (1999), Kwaliteitsinstituut voor de Gezondheidszorg CBO, Utrecht
26. Duijm L.E., Groenewoud J.H., Jansen F.H., et al. Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening. Br J Cancer 91 (2004) 1795-1799
27. Boer R., de Koning H.J., van Oortmarssen G.J., et al. In search of the best upper age limit for breast cancer screening. Eur J Cancer 31A (1995) 2040-2043
28. Fracheboud J., Groenewoud J.H., Boer R., et al. Seventy-five years is an appropriate upper age limit for population-based mammography screening. Int J Cancer 118 (2006) 2020-2025
29. Lynge E., Olsen A.H., Fracheboud J., et al. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev 12 (2003) 213-222
30. Yankaskas B.C., Klabunde C.N., Ancelle-Park R., et al. International comparison of performance measures for screening mammography: can it be done?. J Med Screen 11 (2004) 187-193
31. Otten J.D., Karssemeijer N., Hendriks J.H., et al. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 97 (2005) 748-754
32. Fracheboud J., and de Koning H. (Calculation and interpretation of interval cancers in the Dutch breast cancer screening programme: false-negative is not always false). MemoRad 6 (2001) 8-12
33. Netherlands Cancer Registry. Incidence of Cancer in The Netherlands 1989 (1992), SIG Health Care Information, Utrecht
34. Fracheboud J., de Koning H.J., Beemsterboer P.M., et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 81 (1999) 912-917
35. Taylor R., Supramaniam R., Rickard M., et al. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes. J Med Screen 9 (2002) 20-25
36. NETCB (National Expert and Training Centre for Breast Cancer Screening). Visitaties 2003 (Addendum jaarverslag 2003) (2004), Landelijk Referentiecentrum voor bevolkingsonderzoek op Borstkanker (LRCB), Nijmegen
37. Netherlands Cancer Registry: Incidence of Cancer in The Netherlands 2003. Available from: http://www.ikcnet.nl.
38. de Koning H.J., Draisma G., Fracheboud J., et al. Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data. Breast Cancer Res 8 (2006) 202
39. Fracheboud J., Otto S.J., van Dijck J.A., et al. Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 91 (2004) 861-867
40. van den Akker-van Marle E., de Koning H., Boer R., et al. Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: comparison with the United Kingdom. J Med Screen 6 (1999) 30-34
41. Hakama M., Pukkala E., Heikkila M., et al. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. Br Med J 314 (1997) 864-867
42. Blanks R.G., Moss S.M., McGahan C.E., et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. Br Med J 321 (2000) 665-669
43. Jonsson H., Tornberg S., Nyström L., et al. Service screening with mammography of women aged 70-74 years in Sweden. Effects on breast cancer mortality. Cancer Detect Prev 27 (2003) 360-369
44. Olsen A.H., Njor S.H., Vejborg I., et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. Br Med J 330 (2005) 220
45. Botha J.L., Bray F., Sankila R., et al. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39 (2003) 1718-1729
46. Vervoort M.M., Draisma G., Fracheboud J., et al. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 91 (2004) 242-247
47. Otto S.J., Fracheboud J., Looman C.W., et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361 (2003) 1411-1417
48. de Koning H.J. Screening for breast cancer, time to think-and stop?. National Evaluation Team for Breast Cancer Screening (NETB). Lancet 346 (1995) 438-439
49. Beemsterboer P.M., Warmerdam P.G., Boer R., et al. Radiation risk of mammography related to benefit in screening programmes: a favorable balance?. J Med Screen 5 (1998) 81-87
50. Olsen O., and Gøtzsche P.C. Screening for Breast Cancer with Mammography (Cochrane Review) (2001), John Wiley & Sons, Chichester
51. Giard R.W.M., and Bonneux L. (Breast cancer screening lacking effectiveness). Ned Tijdschr Geneeskd 145 (2001) 2205-2208
52. Gezondheidsraad: (The benefit of population screening for breast cancer with mammography) (2002), Gezondheidsraad, Den Haag Report No.: Publicatie nr 2002/03
53. de Koning H.J., Fracheboud J., Verbeek A.L., et al. (The scientific basis for breast-cancer screening in the Netherlands) De wetenschappelijke basis van het bevolkingsonderzoek naar borstkanker in Nederland. Ned Tijdschr Geneeskd 146 (2002) 1034-1041
54. Cady B., and Chung M. Mammographic screening: no longer controversial. Am J Clin Oncol 28 (2005) 1-4
55. Irwig L., Houssami N., and van Vliet C. New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer 90 (2004) 2118-2122
56. Fischer U., Hermann K.P., and Baum F. Digital mammography: current state and future aspects. Eur Radiol 16 (2006) 38-44
57. Dershaw D.D. Film or digital mammographic screening?. N Engl J Med 353 (2005) 1846-1847
58. Zapka J.G., Geller B.M., Bulliard J.L., et al. Print information to inform decisions about mammography screening participation in 16 countries with population-based programs. Patient Educ Couns 63 (2006) 126-137